Related references
Note: Only part of the references are listed.Cause-specific mortality in children and young adults with diabetes mellitus: A Danish nationwide cohort study
Jesper Svane et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention
Ruth F. Dubin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Chronic Diabetes Complications: The Need to Move beyond Classical Concepts
Didac Mauricio et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial
Nete Tofte et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Omics research in diabetic kidney disease: new biomarker dimensions and new understandings?
Nete Tofte et al.
JOURNAL OF NEPHROLOGY (2020)
Integrated multi-omics approaches to improve classification of chronic kidney disease
Sean Eddy et al.
NATURE REVIEWS NEPHROLOGY (2020)
Circulating TNF receptors and risk of renal disease progression, cardiovascular disease events and mortality in patients with diabetes: a systematic review and meta-analysis
Dongsheng Cheng et al.
ENDOCRINE (2020)
Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 as Biomarkers for Diabetic Kidney Disease
Fatemeh Abbasi et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2020)
The Evolving Treatment of Diabetic Retinopathy
Sam E. Mansour et al.
CLINICAL OPHTHALMOLOGY (2020)
Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy
Gidon J. Boenhof et al.
ENDOCRINE REVIEWS (2019)
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
Monika A. Niewczas et al.
NATURE MEDICINE (2019)
Biomarker panels associated with progression of renal disease in type 1 diabetes
Marco Colombo et al.
DIABETOLOGIA (2019)
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
Stephanie Eid et al.
DIABETOLOGIA (2019)
Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Annabelle M. Warren et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
Keiichiro Matoba et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy
Changyow C. Kwan et al.
CURRENT DIABETES REPORTS (2019)
Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy
Hannah Youngblood et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Need for Multi-Omics Biomarker Signatures in Precision Medicine
Michael Olivier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Tear film substance P: A potential biomarker for diabetic peripheral neuropathy
Shyam Sunder Tummanapalli et al.
OCULAR SURFACE (2019)
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study
Monia Garofolo et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study
Lasse Bjerg et al.
DIABETOLOGIA (2019)
Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention
Dinesh Selvarajah et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Diabetic kidney diseases revisited: A new perspective for a new era
Haiyan Fu et al.
MOLECULAR METABOLISM (2019)
Cardiovascular disease in type 1 diabetes
Harish Sharma et al.
CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM (2019)
Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease
Helen C. Looker et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2018)
Biomarkers of diabetic kidney disease
Helen M. Colhoun et al.
DIABETOLOGIA (2018)
Biomarkers as drug development tools: discovery, validation, qualification and use
Virginia B. Kraus
NATURE REVIEWS RHEUMATOLOGY (2018)
Role of inflammatory biomarkers in diabetic peripheral neuropathy
Heung Yong Jin et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
Araz Rawshani et al.
LANCET (2018)
ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents
Kim C. Donaghue et al.
PEDIATRIC DIABETES (2018)
Metabolomics window into diabetic complications
Tao Wu et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
Rodica Pop-Busui et al.
DIABETES CARE (2017)
Retinal vascular geometry and its association to microvascular complications in patients with type 1 diabetes: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987)
M. L. Rasmussen et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2017)
Clinical predictive factors in diabetic kidney disease progression
Nicholas J. Radcliffe et al.
JOURNAL OF DIABETES INVESTIGATION (2017)
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Eugene J. Barrett et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Nrf2: a potential therapeutic target for diabetic neuropathy
Anil Kumar et al.
INFLAMMOPHARMACOLOGY (2017)
Diabetic Kidney Disease Challenges, Progress, and Possibilities
Radica Z. Alicic et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Metabolomics of Diabetic Retinopathy
Gerald Liew et al.
CURRENT DIABETES REPORTS (2017)
Vascular complications in diabetes: old messages, new thoughts
Josephine M. Forbes et al.
DIABETOLOGIA (2017)
Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes
Sara J. Jenks et al.
DIABETOLOGIA (2017)
Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy
Arash Bidadkosh et al.
DIABETES CARE (2017)
Proinflammatory Cytokines Predict the Incidence and Progression of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study
Christian Herder et al.
DIABETES CARE (2017)
Biomarkers of Diabetic Retinopathy
Daniel Shu Wei Ting et al.
CURRENT DIABETES REPORTS (2016)
Overview of Systems Biology and Omics Technologies
Bensu Karahalil
CURRENT MEDICINAL CHEMISTRY (2016)
Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease
Michelle J. Pena et al.
DIABETOLOGIA (2016)
Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010
Shona J. Livingstone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Proteomic biomarkers in kidney disease: issues in development and implementation
Harald Mischak et al.
NATURE REVIEWS NEPHROLOGY (2015)
New Insights Into the Use of Biomarkers of Diabetic Nephropathy
Jay C. Jha et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2014)
Albuminuria: When urine predicts kidney and cardiovascular disease
Reejis Stephen et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2014)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Mechanisms of Disease Diabetic Retinopathy
David A. Antonetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Biomarkers: hopes and challenges in the path from discovery to clinical practice
Nikolaos G. Frangogiannis
TRANSLATIONAL RESEARCH (2012)
Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers
Timothy J. Lyons et al.
TRANSLATIONAL RESEARCH (2012)
Role of Chronic and Acute Hyperglycemia in the Development of Diabetes Complications
M. Loredana Marcovecchio et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
David M. Good et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
Per-Henrik Groop et al.
DIABETES (2009)
Diabetic microvascular complications: can patients at risk be identified? A review
A. Girach et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Diabetic microvascular complications - can the presence of one predict the development of another?
Aniz Girach et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
High risk of cardiovascular disease in patients with type 1 diabetes in the UK - A cohort study using the General Practice Research Database
SS Soedamah-Muthu et al.
DIABETES CARE (2006)
Vascular complications in diabetes mellitus: the role of endothelial dysfunction
CG Schalkwijk et al.
CLINICAL SCIENCE (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Share Paper
